Arcoxia as Effective as Ibuprofen

JUNE 01, 2005

A study from Merck Laboratories has shown cyclooxygenase-2 (COX-2) inhibitor etoricoxib (Arcoxia) to be as effective as ibuprofen for treating pain associated with arthritis. The 12-week study included 528 patients being treated for arthritis of the hip and knee and compared Arcoxia with ibuprofen and placebo.

It took about 2 weeks for Arcoxia and ibuprofen to achieve maximum effectiveness, with symptom control lasting for another 10 weeks. Both drugs performed better than placebo and generally were well tolerated. Arcoxia is a new COX-2 inhibitor and, as such, has been scrutinized by the FDA along with Vioxx and other members of that class of drugs for a possible link to heart attack and stroke.



SHARE THIS SHARE THIS
0

Conference Coverage

Check back here regularly for live conference coverage from the American Academy of Pain Medicine and the upcoming American Pharmacists Association Meeting and Expo. 


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.